| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/16/2012 | US20120039859 Method of Diminishing The Symptoms of Neurodegenerative Disease |
| 02/16/2012 | US20120039849 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase |
| 02/16/2012 | US20120039844 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation |
| 02/16/2012 | US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors |
| 02/16/2012 | US20120038073 Spray drying methods and related compositions |
| 02/16/2012 | CA2845198A1 Ggf2 and methods of use |
| 02/16/2012 | CA2808251A1 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof |
| 02/16/2012 | CA2808016A1 Novel 6,7-disubstituted-isoquinoline derivatives and their use |
| 02/16/2012 | CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 02/16/2012 | CA2807946A1 Treatment of penetrative injury to the brain |
| 02/16/2012 | CA2807855A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms |
| 02/16/2012 | CA2807687A1 6-cycloalkyl-1, 5-dihydro-pyrazolo (3,4-d) pyrimidin-4-one derivatives and their use as pde9a inhibitors |
| 02/16/2012 | CA2807661A1 Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease |
| 02/16/2012 | CA2807616A1 Methods and compositions for preventing a condition |
| 02/16/2012 | CA2807538A1 Novel trpv3 modulators |
| 02/16/2012 | CA2807460A1 Heterocyclic compound and use thereof |
| 02/16/2012 | CA2807359A1 Inhibitor of casein kinase 1.delta. and casein kinase 1.epsilon. |
| 02/16/2012 | CA2806658A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806646A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806644A1 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806643A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2805114A1 Anti-n3pglu amyloid beta peptide antibodies and uses thereof |
| 02/16/2012 | CA2803656A1 Combination of glyt1 compound with antipsychotics |
| 02/15/2012 | EP2418201A1 Polymorph forms of (2S) - (4E) -N-methyl-5- (3-isopropoxypyridin) yl]-4-penten-2-amine for the treatment of central nervous system disorders |
| 02/15/2012 | EP2418196A1 Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors |
| 02/15/2012 | EP2418191A1 Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same |
| 02/15/2012 | EP2417985A1 Mitochondrial function-improving agent |
| 02/15/2012 | EP2417976A1 Process for production of orally ingestible composition containing arabinosyl vitexin, and use of the composition |
| 02/15/2012 | EP2417973A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO Ý4, 3-b¨INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE |
| 02/15/2012 | EP2417135A1 Substituted triazolopyridines and analogs thereof |
| 02/15/2012 | EP2417130A2 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof |
| 02/15/2012 | EP2417124A2 Serotonin and norepinephrine reuptake inhibitor |
| 02/15/2012 | EP2417115A1 Inhibitors of fatty acid amide hydrolase |
| 02/15/2012 | EP2416655A1 Methods for preventing and/or treating degenerative disorders of the central nervous system |
| 02/15/2012 | EP2321286B1 Substituted n-oxide pyrazine derivatives |
| 02/15/2012 | EP1885333B1 Pharmaceutical formulation of apomorphine for buccal administration |
| 02/15/2012 | EP1797077B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 02/15/2012 | EP1765861B1 Fgfr binding peptides |
| 02/15/2012 | EP1644019B1 Abuse resistant amphetamine compounds |
| 02/15/2012 | EP1532446B1 G-protein coupled receptor ligands and methods |
| 02/15/2012 | EP1532161B1 Vectors for expression of hml-2 polypeptides |
| 02/15/2012 | EP1381432B1 HSA-free formulations of interferon-beta |
| 02/15/2012 | CN102356156A Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle |
| 02/15/2012 | CN102356084A N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same |
| 02/15/2012 | CN102356081A Bicyclic compounds for the reduction of beta-amyloid production |
| 02/15/2012 | CN102356079A Amide derivatives as neuropeptide y5 receptor ligands |
| 02/15/2012 | CN102356071A Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production a novel alpha-(n-sulfonamido) acetamide compound incorporating deuterium as inhibitor of beta amyloid peptide production |
| 02/15/2012 | CN102356061A Method for producing bicyclic g-amino acid derivative |
| 02/15/2012 | CN102355905A Stroke-generated angiogenesis enhancers and uses thereof |
| 02/15/2012 | CN102355902A Treatment of neurotrophic factor mediated disorders |
| 02/15/2012 | CN102355900A Administration regime for nitrocatechols |
| 02/15/2012 | CN102355897A Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
| 02/15/2012 | CN102352358A Seventy-four rat source miRNA (ribonucleic acid) as well as corresponding miRNA precursor and antisense oligonucleotide thereof |
| 02/15/2012 | CN102352355A Compositions and methods for short interfering nucleic acid inhibition of NAv1.8 |
| 02/15/2012 | CN102351958A Preparation method and application of astragalus polysaccharide-calcium complex |
| 02/15/2012 | CN102351951A Purification method, extract and preparation of cobra venom neurotoxin |
| 02/15/2012 | CN102351934A Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds |
| 02/15/2012 | CN102351880A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 02/15/2012 | CN102351854A Amino thiazole derivative and preparation method and medical purpose thereof |
| 02/15/2012 | CN102351732A Nuclear receptor binding agents |
| 02/15/2012 | CN102349987A Traditional Chinese medicinal composition for treating epilepsy and preparation method thereof |
| 02/15/2012 | CN102349976A Traditional Chinese medicine for treating insomnia |
| 02/15/2012 | CN102349968A Traditional Chinese medicine for treating insomnia |
| 02/15/2012 | CN102349960A Traditional Chinese medicine for treating neurodynia caused by herpes zoster |
| 02/15/2012 | CN102349940A Process for preparing thermopsis lanceolate total alkaloids and several high-purity medicinal substances |
| 02/15/2012 | CN102349914A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/15/2012 | CN102349908A Application of dexrazoxane in preparation of drug for treating neurodegenerative diseases |
| 02/15/2012 | CN102349907A Medicament for treating schizophrenia comprising cilostazol |
| 02/15/2012 | CN102349893A Edaravone pharmaceutical composition |
| 02/15/2012 | CN102349885A Medicament for treating senile dementia |
| 02/15/2012 | CN102349883A Acetaminophen oral instant membrane and preparation method thereof |
| 02/15/2012 | CN102349879A Desmethylvenlafaxine controlled release tablet and preparation method thereof |
| 02/15/2012 | CN102349873A Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof |
| 02/15/2012 | CN102349701A Chinese herbal medicine cigarette and manufacturing method thereof |
| 02/15/2012 | CN102091231B 一种治疗神经衰弱的中药组合物 A neurasthenic medicine composition for treating |
| 02/15/2012 | CN102008638B 一种治疗心病型神经衰弱的药物 A heart-type medications neurasthenia |
| 02/15/2012 | CN101991625B 大惊丸及其制备方法 Startled pill and its preparation method |
| 02/15/2012 | CN101948464B 3,4,6-三芳基-[1,3]-噁嗪-2-酮类化合物、其制备方法和用途 3,4,6-triaryl - [1,3] - oxazin-2-ones compounds, their preparation and use |
| 02/15/2012 | CN101863839B N-3-芳酰胺-5-环丙烷螺环乙内酰脲衍生物及其制备方法和应用 N-3- aramid -5- cyclopropane spiro hydantoin derivatives, preparation method and application |
| 02/15/2012 | CN101822841B 有机胺衍生物作为小分子药物脑靶向修饰基团的用途 Organic amine derivatives as small molecule drugs targeting the brain uses a modified group |
| 02/15/2012 | CN101732356B 一种治疗颈肩腰腿痛的提脓拔毒膏 A treatment for neck and back pain mention pus Sida cream |
| 02/15/2012 | CN101550173B 4-(4-β-D-吡喃阿洛糖苷-苯基)-2-芳基-5-腈基-6-甲氧基吡啶及其制备方法与应用 4- (4-β-D- glucoside pyran Alor - phenyl) -2-aryl-5-nitrile-6-methoxy pyridine and its preparation method and application |
| 02/15/2012 | CN101530389B 人参皂苷Rg3磷脂复合物及其制备方法 Ginsenoside Rg3 phospholipid complex and its preparation method |
| 02/15/2012 | CN101528213B 莫达非尼和h3受体拮抗体或反向激动剂的组合 Modafinil and h3 receptor antagonists or inverse agonists in combination |
| 02/15/2012 | CN101310751B 一种具有益气养血作用的药物组合物的检测方法 BNI detection method has the effect of a pharmaceutical composition |
| 02/15/2012 | CN101065123B 药物依赖症治疗剂 Drug addiction treatment agent |
| 02/15/2012 | CN101022795B L-色氨酸与卡比多巴/苄丝肼的制剂 L- tryptophan and carbidopa / benserazide preparations |
| 02/14/2012 | US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/14/2012 | US8114981 Method and medicament for inhibiting the expression of a given gene |
| 02/14/2012 | US8114896 Method and composition for potentiating an opiate analgesic |
| 02/14/2012 | US8114892 Methods and compositions for the treatment of Parkinson's Disease |
| 02/14/2012 | US8114860 GABA-steroid antagonists and their use for the treatment of CNS disorders |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114840 Medicament containing activated antithrombin III |
| 02/14/2012 | US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 |
| 02/14/2012 | US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 02/14/2012 | CA2522179C Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
| 02/09/2012 | WO2012019113A2 Inhibitors of erk for developmental disorders of neuronal connectivity |
| 02/09/2012 | WO2012019021A1 Methods and pharmaceutical compositions for treating adverse or deleterious sequellae of traumatic brain injury |